Is laterality in breast Cancer still worth studying? Local experience in Bahrain

• Published in: BMC cancer 2022-09, Vol.22 (1), p.1-968, Article 968
• Main Authors: Al Saad, Suhair, Al Shenawi, Hamdi, Almarabheh, Amer, Al Shenawi, Noor, Mohamed, Abdulla Ismaeel, Yaghan, Rami
• Format: Article
• Language: English
• Subjects: Age; Bahrain 3; Breast cancer; Breast cancer 1; Breastfeeding & lactation; Care and treatment; Development and progression; ErbB-2 protein; Estrogens; Family history 5; Family medical history; Genetic aspects; Laterality 2; Lymph nodes; Lymphatic system; Malignancy; Mammography; Medical prognosis; Metastases; Metastasis; Methods; Ovarian cancer; Patients; Population studies; Size of tumor 6; Statistical analysis; Survival; Survival analysis; Tumor stage 4; Tumor staging; Tumors; Variables
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-022-10063-y

Background Laterality in breast cancer means an increased frequency of left-sided breast cancers compared to right-sided breast cancers ranging between 1.05 and 1.26. It was first described in 1935 by Fellenberg, Sweden. The explanation of this phenomenon is not clear, but the association with other factors was found. This study aimed to explore the laterality of breast cancer in Bahrain as a model for Arabian countries. The association of laterality with the clinicopathological characteristics of the tumor was also analyzed to explore any applied clinical value. Methods This is a cross-sectional, retrospective review of a particular ethnic population to study laterality of breast cancer versus a number of clinicopathological factors, as well as prognosis. The study analyzed 228 breast cancer patients treated in Arabian Gulf University facilities in Bahrain between 1999 and 2020. Three bilateral breast cancer and two malignant phyllodes patients were excluded. The following variables were analyzed: laterality ratio (Lt/Rt) and the association between laterality and clinicopathological characteristics (age at diagnosis, family history of malignancy, size of the tumor, tumor grade, histological type, hormonal receptors and HER2, axillary lymph node status, tumor stage, five-year survival rate, nulliparity, and multifocality). Results The laterality ratio (Lt/Rt) was 1.06 and was 0.97 for patients below 50 years of age, and 1.19 for patients 50 years of age and above. Analysis of our data showed a statistically significant association between laterality and tumor stage (p. value =0.025) at presentation, and laterality and family history of malignancy (p. value =0.052). Right-sided breast cancer was associated with a higher positive family history of malignancy and an increased ratio of locally advanced and metastatic disease, and a reduced 5-year survival in relation to size and stage. Left-sided breast cancer was associated with higher early tumor stage. Conclusion This is the first study exploring the issue of breast cancer laterality in a defined Arabian population. The laterality ratio in this study was 1.06, which is consistent with the globally published range (1.05 to 1.26) and is increasing with increasing age. The association between breast cancer laterality, and the hormonal and HER2 is still not widely addressed in the available literature, although other clinicopathological characteristics were extensively analyzed. Keywords: Breast cancer 1, Late